Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine/atorvastatin for hypertension and dyslipidemia
NCT00143234Phase 3Completed
- Sponsor
- Viatris
- Start
- May 2004
- Modality
- Small Molecules
- Countries
- 27
01
Overview
Phase 3, open-label, single-arm trial of amlodipine and atorvastatin in hypertension (HTN) and hyperlipidemia, sponsored by Viatris. Primary endpoint: Percentage of intent-to-treat subjects achieving both blood pressure (JNC VII) and lipid treatment goals (NCEP ATP III) at 14 weeks. Started May 2004; status: completed.
02
Drugs
amlodipineatorvastatin
03
Conditions
hypertension (HTN)hyperlipidemia
Beyond the preview
Go deeper on NCT00143234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00143234.